Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution

PLoS Genetics

Volumn 12, Issue 2, 2016, Pages

  Uchi, Ryutaro ^a,b   Takahashi, Yusuke ^a,c   Niida, Atsushi ^d   Shimamura, Teppei ^d   Hirata, Hidenari ^a   Sugimachi, Keishi ^a   Sawada, Genta ^a,c   Iwaya, Takeshi ^e   Kurashige, Junji ^a   Shinden, Yoshiaki ^a   Iguchi, Tomohiro ^a   Eguchi, Hidetoshi ^a   Chiba, Kenichi ^d   Shiraishi, Yuichi ^d   Nagae, Genta ^f   Yoshida, Kenichi ^g   Nagata, Yasunobu ^g   Haeno, Hiroshi ^h   Yamamoto, Hirofumi ^c   Ishii, Hideshi ^c   Doki, Yuichiro ^c   Iinuma, Hisae ⁱ   Sasaki, Shin ^j   Nagayama, Satoshi ^k   Yamada, Kazutaka ^l   Yachida, Shinichi ^m   Kato, Mamoru ^m   Shibata, Tatsuhiro ^m   Oki, Eiji ^b   Saeki, Hiroshi ^b   Shirabe, Ken ^b   Oda, Yoshinao ^b   Maehara, Yoshihiko ^b   Komune, Shizuo ^b   Mori, Masaki ^c   Suzuki, Yutaka ^d   Yamamoto, Ken ⁿ   Aburatani, Hiroyuki ^f   Ogawa, Seishi ^g   Miyano, Satoru ^d   Mimori, Koshi ^a   more..

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

^h KYOTO UNIVERSITY   (Japan)

ⁱ TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j Omori Red Cross Hospital   (Japan)

^k CANCER INSTITUTE HOSPITAL   (Japan)

^l TAKANO HOSPITAL   (Japan)

^m NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

ⁿ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EVOLUTIONARY ADAPTATION; GENE MUTATION; GENETIC ANALYSIS; GENOME; HUMAN; TREATMENT FAILURE; AGED; AGING; BIOLOGICAL MODEL; COLORECTAL TUMOR; EVOLUTION; EXOME; FEMALE; FOUNDER EFFECT; GENETIC EPIGENESIS; GENETICS; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL EVOLUTION; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EXOME; FEMALE; FOUNDER EFFECT; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84959902916     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1005778     Document Type: Article

References (39)

1. McGranahan N, Swanton C, Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution. Cancer cell. 2015;27(1):15–26. Epub 2015/01/15. doi: 10.1016/j.ccell.2014.12.00125584892.
2. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467(7319):1114–7. doi: 10.1038/nature0951520981102; PubMed Central PMCID: PMC3148940.
3. Gerlinger M, Horswell S, Larkin J, Rowan AJ, Salm MP, Varela I, et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nature genetics. 2014;46(3):225–33. doi: 10.1038/ng.289124487277.
4. de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science. 2014;346(6206):251–6. doi: 10.1126/science.125346225301630.
5. Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014;346(6206):256–9. doi: 10.1126/science.125693025301631.
6. Aryee MJ, Liu W, Engelmann JC, Nuhn P, Gurel M, Haffner MC, et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Science translational medicine. 2013;5(169):169ra10. Epub 2013/01/25. doi: 10.1126/scitranslmed.300521123345608; PubMed Central PMCID: PMCPMC3577373.
7. Brocks D, Assenov Y, Minner S, Bogatyrova O, Simon R, Koop C, et al. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell reports. 2014;8(3):798–806. doi: 10.1016/j.celrep.2014.06.05325066126.
8. Cancer Genome Atlas N, Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–7. doi: 10.1038/nature1125222810696; PubMed Central PMCID: PMC3401966.
9. Hall BG, Building phylogenetic trees from molecular data with MEGA. Molecular biology and evolution. 2013;30(5):1229–35. Epub 2013/03/15. doi: 10.1093/molbev/mst01223486614.
10. Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, et al. A Big Bang model of human colorectal tumor growth. Nature genetics. 2015;47(3):209–16. Epub 2015/02/11. doi: 10.1038/ng.321425665006.
11. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–21. doi: 10.1038/nature1247723945592; PubMed Central PMCID: PMC3776390.
12. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome research. 2012;22(2):271–82. Epub 2011/06/11. doi: 10.1101/gr.117523.11021659424; PubMed Central PMCID: PMCPMC3266034.
13. Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–30. Epub 2015/02/20. doi: 10.1038/nature1424825693563; PubMed Central PMCID: PMCPMC4530010.
14. Jones PA, Baylin SB, The epigenomics of cancer. Cell. 2007;128(4):683–92. doi: 10.1016/j.cell.2007.01.02917320506; PubMed Central PMCID: PMC3894624.
15. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP, Aging and DNA methylation in colorectal mucosa and cancer. Cancer research. 1998;58(23):5489–94. Epub 1998/12/16. 9850084.
16. Niida A, Ito S, Tremmel G, Imoto S, Uchi R, Takahashi Y, et al. Cancer evolution simulation identifies possible principles underlying intratumor heterogeneity; 2015. Preprint. Available: bioRxiv. doi: 10.1101/022806 Accessed 1 September 2015.
17. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G, The hallmarks of aging. Cell. 2013;153(6):1194–217. Epub 2013/06/12. doi: 10.1016/j.cell.2013.05.03923746838; PubMed Central PMCID: PMCPMC3836174.
18. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150(2):264–78. Epub 2012/07/24. doi: 10.1016/j.cell.2012.06.02322817890; PubMed Central PMCID: PMCPMC3407563.
19. Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature genetics. 2012;44(6):651–8. doi: 10.1038/ng.227022561519; PubMed Central PMCID: PMC3372921.
20. Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nature medicine. 2014;20(12):1472–8. doi: 10.1038/nm.373325326804; PubMed Central PMCID: PMC4313872.
21. Tomasetti C, Vogelstein B, Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015;347(6217):78–81. Epub 2015/01/03. doi: 10.1126/science.126082525554788.
22. Wang Y, Waters J, Leung ML, Unruh A, Roh W, Shi X, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature. 2014;512(7513):155–60. doi: 10.1038/nature1360025079324; PubMed Central PMCID: PMC4158312.
23. Diaz LA, Jr.Williams RT, Wu J, Kinde I, Hecht JR, Berlin J, et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature. 2012;486(7404):537–40. Epub 2012/06/23. doi: 10.1038/nature1121922722843; PubMed Central PMCID: PMCPMC3436069.
24. Muto T, Bussey HJ, Morson BC, The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251–70. Epub 1975/12/01. 1203876.
25. Fearon ER, Vogelstein B, A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–67. Epub 1990/06/01. 2188735.
26. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, et al. Comparative lesion sequencing provides insights into tumor evolution. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(11):4283–8. Epub 2008/03/14. doi: 10.1073/pnas.071234510518337506; PubMed Central PMCID: PMCPMC2393770.
27. Markowitz SD, Bertagnolli MM, Molecular origins of cancer: Molecular basis of colorectal cancer. The New England journal of medicine. 2009;361(25):2449–60. Epub 2009/12/19. doi: 10.1056/NEJMra080458820018966; PubMed Central PMCID: PMCPMC2843693.
28. Zeuner A, Todaro M, Stassi G, De Maria R, Colorectal cancer stem cells: from the crypt to the clinic. Cell stem cell. 2014;15(6):692–705. Epub 2014/12/07. doi: 10.1016/j.stem.2014.11.01225479747.
29. Sottoriva A, Graham T, A pan-cancer signature of neutral tumor evolution; 2015. Preprint. Available: bioRxiv. doi: 10.1101/014894 Accessed 1 September 2015.
30. Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, et al. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer. Annals of surgical oncology. 2013;20(4):1395–402. Epub 2012/09/15. doi: 10.1245/s10434-012-2657-z22976378.
31. Shiraishi Y, Sato Y, Chiba K, Okuno Y, Nagata Y, Yoshida K, et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic acids research. 2013;41(7):e89. Epub 2013/03/09. doi: 10.1093/nar/gkt12623471004; PubMed Central PMCID: PMCPMC3627598.
32. Van Loo P, Nordgard SH, Lingjaerde OC, Russnes HG, Rye IH, Sun W, et al. Allele-specific copy number analysis of tumors. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(39):16910–5. Epub 2010/09/15. doi: 10.1073/pnas.100984310720837533; PubMed Central PMCID: PMCPMC2947907.
33. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer cell. 2014;25(1):91–101. Epub 2014/01/18. doi: 10.1016/j.ccr.2013.12.01524434212; PubMed Central PMCID: PMCPMC4241387.
34. Takahashi Y, Sheridan P, Niida A, Sawada G, Uchi R, Mizuno H, et al. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2015. Epub 2015/01/30. doi: 10.1093/annonc/mdv03425632068.
35. Johnson WE, Li C, Rabinovic A, Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (Oxford, England). 2007;8(1):118–27. Epub 2006/04/25. doi: 10.1093/biostatistics/kxj03716632515.
36. Niida A, Smith AD, Imoto S, Aburatani H, Zhang MQ, Akiyama T, Gene set-based module discovery in the breast cancer transcriptome. BMC bioinformatics. 2009;10:71. doi: 10.1186/1471-2105-10-7119243633; PubMed Central PMCID: PMC2674431.
37. Csillery K, Blum MG, Gaggiotti OE, Francois O, Approximate Bayesian Computation (ABC) in practice. Trends in ecology & evolution. 2010;25(7):410–8. Epub 2010/05/22. doi: 10.1016/j.tree.2010.04.00120488578.
38. Miller CA, White BS, Dees ND, Griffith M, Welch JS, Griffith OL, et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS computational biology. 2014;10(8):e1003665. doi: 10.1371/journal.pcbi.100366525102416; PubMed Central PMCID: PMC4125065.
39. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature genetics. 2006;38(7):787–93. Epub 2006/06/29. doi: 10.1038/ng183416804544.